BIIB vs FUNC · P/E 21, rev $9.89B vs P/E 10, rev $17.7M
Biogen Inc (BIIB) versus First United Corporation (FUNC) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
First United Corporation (FUNC) is a banks - regional company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported FUNC revenue for 2024-12-31 was $17.7M. Net income was $20.6M. Revenue was up 6.3% from 2023-12-31 to 2024-12-31. FUNC currently screens at market cap $263.4M and trailing P/E 10.5.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. FUNC currently screens at market cap $263.4M and trailing P/E 10.5.
Not investment advice. Open the BIIB and FUNC stock pages for the full models.
Not investment advice.